Murchinson’s SpringWorks Therapeutics SWTX Stock Holding History

Murchinson’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-50,000	Closed	-$2.35M	–	124
2025 Q2	$2.35M	Hold	50,000	–	–	0.83%	22
2025 Q1	$2.21M	Buy	+50,000	New	+$2.3M	0.12%	43

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Murchinson's SWTX Position: Q3 2025 in Review

Murchinson sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 50,000 shares — an estimated $2.35M sold.

Murchinson first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $2.35M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Murchinson reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Murchinson sold 50,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $2.35M.
Murchinson first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Murchinson's SpringWorks Therapeutics position peaked at $2.35M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Murchinson's 13F filing for Q3 2025, filed 14 Nov 2025.